← Ishga qaytish
Ushbu ish iqtibos qilgan ishlar
35 ta ish
Ish: Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)
International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV) and the register “Analysis of hospitalizations of comorbid patients infected during the second wave of SARS-CoV-2 outbreak” (AKTIV 2)
G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov +97
MaqolaOchiq kirish20215 iqtibosABIPhenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
Bertrand Cariou, Samy Hadjadj, Matthieu Wargny +38
MaqolaOchiq kirish20203 iqtibosABIInhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
Kayleigh M Kew, Alieksei Seniukovich
Sharh maqolaOchiq kirish20142 iqtibosABIMay statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?
Roberto Scicali, Antonino Di Pino, Salvatore Piro +2
Sharh maqolaOchiq kirish20202 iqtibosABIMetformin and COVID-19: From cellular mechanisms to reduced mortality
Sharh maqolaOchiq kirish20202 iqtibosABIStatins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
Fotios Barkas, Haralampos Milionis, Georgia Anastasiou +1
Sharh maqolaOchiq kirish20202 iqtibosABI